Author

A. Bergh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Schörling· 1 shared A. Thoss· 1 shared C.-J. Eriksson· 1 shared G. Grobner· 1 shared H. Druid· 1 shared H. T. Sorensen· 1 shared H.-O. Adami· 1 shared I. Dudka· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Schörling

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Metabolic readouts of tumor instructed normal tissues (TINT) identify aggressive prostate cancer subgroups for tailored therapy

I. Dudka, P. Wikstrom, A. Bergh, G. Grobner

The paper identifies metabolic signatures in benign prostate tissues near tumors using HR MAS NMR, revealing differences associated with tumor grade and proximity, which could improve prostate cancer diagnostics.

bioRxiv · Apr 29, 2024Cancer Biology

Cytomegalovirus promotes proliferation and survival of prostate cancer cells and constitutes a therapeutic target

J. Classon, M. Stenudd, M. Zamboni, K. Alkass, C.-J. Eriksson, L. Pedersen, A. Schörling, A. Thoss, A. Bergh, P. Wikström, H.-O. Adami, H. T. Sorensen, H. Druid, J. Frisen

This study shows CMV infects prostate cancer cells, promotes their survival and proliferation, and can be targeted therapeutically with maribavir.

bioRxiv · Oct 1, 2023 · PreprintCancer Biology